Charles River Laboratories International, Inc. (CRL)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 317.85 |
| Open | 322.42 |
| Bid | 312.10 x 800 |
| Ask | 378.97 x 800 |
| Day's range | 308.50 - 324.36 |
| 52-week range | 253.04 - 460.21 |
| Volume | |
| Avg. volume | 412,398 |
| Market cap | 15.688B |
| Beta (5Y monthly) | 1.17 |
| PE ratio (TTM) | 40.26 |
| EPS (TTM) | 7.72 |
| Earnings date | 16 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 443.73 |
- Business Wire
Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call
WILMINGTON, Mass., January 20, 2022--Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call
- Zacks
3 Reasons Why Charles River (CRL) Is a Great Growth Stock
Charles River (CRL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Business Wire
Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions
WILMINGTON, Mass. & BOSTON, January 19, 2022--Charles River and Valo Health announce a multiyear strategic partnership to provide clients with access to AI-enabled drug discovery.
© 2022 Yahoo. All rights reserved.
